Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14: 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism - Siegmund, W; Spieker, K; Weike, A I (Clin Endocrinol (Oxf), 2004)
et al.